Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease ovarian cancer
Symptom C0002871|anemia
Sentences 5
PubMedID- 25918604 Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity.
PubMedID- 21381011 The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival.
PubMedID- 23266649 Objective: erythropoiesis-stimulating agents (esas) support chemotherapy-induced anemia in patients with epithelial ovarian cancer (eoc).
PubMedID- 20361359 Alkylating agents or antimetabolites were additional significant predictors of anemia in women with ovarian cancer.
PubMedID- 22123713 Introduction: to evaluate the incidence of anemia in patients with epithelial ovarian cancer receiving paclitaxel-carboplatin combination therapy (tc) using data from the japanese gynecologic oncology group (jgog) 3016 trial, and to examine the effect of severe anemia on survival during dose-dense tc.

Page: 1